Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00938795 · ClinicalTrials.gov registry record · NA
Uncertainty Management Intervention
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 288
- Enrollment target
NCT00938795: Completed NA study, sponsored by Duke University.
NCT00938795 is a NA study that has completed, run by Duke University. The registered enrollment target is 288 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00938795, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 288 participants
- Enrollment target
Study Summary
The goal of this study is to improve symptoms and quality of life for end-stage liver disease patients awaiting a liver transplant and their caregivers by providing them with the resources and tools to self-manage their complex concerns.
Interventions
- OTHER Uncertainty Management Intervention
- OTHER Comparison Conditions for Liver Transplant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 288 participants |
| Start Date | 2010-02 |
| Est. Completion | 2013-09 |
| Phase | NA |
What the finished NCT00938795 record still lists
NCT00938795 is an interventional study that assigns participants to a tested intervention. The registered 288 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).
The record links to 0 conditions, and to 2 interventions - of which Uncertainty Management Intervention is the first listed.
NCT00938795 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00938795 about?
NCT00938795 is a clinical study titled "Uncertainty Management Intervention". The goal of this study is to improve symptoms and quality of life for end-stage liver disease patients awaiting a liver transplant and their caregivers by providing them with the resources and tools to self-manage their complex concerns.
What is the current status of trial NCT00938795?
This trial is currently completed. It is a NA study. The enrollment target is 288 participants. The study started on 2010-02. Estimated completion is 2013-09.
What interventions are being tested in trial NCT00938795?
The interventions under investigation include: Uncertainty Management Intervention (OTHER), Comparison Conditions for Liver Transplant (OTHER).
Who is sponsoring clinical trial NCT00938795?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00938795's enrollment target sits among peer trials
288 376th of 2000 higher than 1,624 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02098265 · 288 participants · NA
A Closed Loop Neural Activity Triggered Stroke Rehabilitation Device
- NCT03741777 · 288 participants · NA
Comparison of Residual Gastric Volume Between Children Who Drink Different Clear Oral Fluid Volume
- NCT03937635 · 288 participants · Phase 3
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
- NCT04621877 · 288 participants · NA
Lay-Delivered Behavioral Activation in Senior Centers
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia